These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28822584)

  • 1. Real-time Watchful Surveillance Looks Like Active Waiting.
    Bangma C; Roobol M
    Eur Urol; 2017 Dec; 72(6):908-909. PubMed ID: 28822584
    [No Abstract]   [Full Text] [Related]  

  • 2. Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer.
    Loeb S; Berglund A; Stattin P
    J Urol; 2013 Nov; 190(5):1742-9. PubMed ID: 23727309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Watchful Waiting-Active Surveillance in Low-Risk Prostate Cancer.
    Haffty BG; Lawton CA; Sandler H
    JAMA Oncol; 2015 Aug; 1(5):688-9. PubMed ID: 26182350
    [No Abstract]   [Full Text] [Related]  

  • 4. Watchful Waiting-Active Surveillance in Low-Risk Prostate Cancer-Reply.
    Williams SB; Chamie K; Hu JC
    JAMA Oncol; 2015 Aug; 1(5):689-90. PubMed ID: 26181144
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer.
    Van Hemelrijck M; Garmo H; Lindhagen L; Bratt O; Stattin P; Adolfsson J
    Eur Urol; 2017 Oct; 72(4):534-541. PubMed ID: 27816297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based assessment of determining predictors for quality of prostate cancer surveillance.
    Chamie K; Williams SB; Hershman DL; Wright JD; Nguyen PL; Hu JC
    Cancer; 2015 Dec; 121(23):4150-7. PubMed ID: 26307939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The experience of adults who choose watchful waiting or active surveillance as an approach to medical treatment: a qualitative systematic review.
    Rittenmeyer L; Huffman D; Alagna M; Moore E
    JBI Database System Rev Implement Rep; 2016 Feb; 14(2):174-255. PubMed ID: 27536798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical prostatectomy trumps watchful waiting in early prostate cancer. Commentary on: Radical prostatectomy or watchful waiting in early prostate cancer.
    Black PC
    Urology; 2014 Aug; 84(2):253-4. PubMed ID: 24958487
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.
    Ibragimova N; Zhanzak Z; Meyerbekova A; Xie Y
    Eur Urol; 2018 Jan; 73(1):143-144. PubMed ID: 29113695
    [No Abstract]   [Full Text] [Related]  

  • 10. Who Should Consider Active Surveillance?
    Albertsen P
    J Urol; 2016 Dec; 196(6):1604-1605. PubMed ID: 27639609
    [No Abstract]   [Full Text] [Related]  

  • 11. Another Reason to Consider Active Surveillance.
    Albertsen PC
    Eur Urol; 2016 Apr; 69(4):582-583. PubMed ID: 26603782
    [No Abstract]   [Full Text] [Related]  

  • 12. "Real-world" Practice Makes Perfect: Ensuring the Active Component of Active Surveillance for Prostate Cancer.
    Weiner AB; Schaeffer EM; Eggener SE
    Eur Urol; 2018 Dec; 74(6):708-709. PubMed ID: 30224197
    [No Abstract]   [Full Text] [Related]  

  • 13. Active Surveillance Doing Well Under Surveillance.
    Ellen O; Jada K; Jiasian T; Nathan L; Declan GM
    Eur Urol Oncol; 2020 Feb; 3(1):92-93. PubMed ID: 31839586
    [No Abstract]   [Full Text] [Related]  

  • 14. A Brief Survey of Active Surveillance.
    Chin JL
    Eur Urol; 2015 Nov; 68(5):812-3. PubMed ID: 25913066
    [No Abstract]   [Full Text] [Related]  

  • 15. The cost-effectiveness of active surveillance compared to watchful waiting and radical prostatectomy for low risk localised prostate cancer.
    Lao C; Edlin R; Rouse P; Brown C; Holmes M; Gilling P; Lawrenson R
    BMC Cancer; 2017 Aug; 17(1):529. PubMed ID: 28789623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inconveniences of active surveillance in prostate cancer.
    Sánchez-de-Badajoz E
    Actas Urol Esp; 2016 Mar; 40(2):69-71. PubMed ID: 26341888
    [No Abstract]   [Full Text] [Related]  

  • 17. Active surveillance: protocol makes perfect.
    van den Bergh RC; Bangma CH
    Eur Urol; 2015 Feb; 67(2):239-40. PubMed ID: 25018039
    [No Abstract]   [Full Text] [Related]  

  • 18. How Often is Biopsy Necessary in Patients with Prostate Cancer on Active Surveillance?
    Bruinsma SM; Bokhorst LP; Roobol MJ; Bangma CH
    J Urol; 2016 Jan; 195(1):11-2. PubMed ID: 26475660
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
    Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Active surveillance of prostatic cancer].
    Vasarainen H; Ruutu M; Rannikko A
    Duodecim; 2011; 127(6):593-9. PubMed ID: 21528523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.